<!doctype html public "-//W3C//DTD W3 HTML//EN">
<html><head><style type="text/css"><!--
blockquote, dl, ul, ol, li { margin-top: 0 ; margin-bottom: 0 }
--></style><title>Fwd: 2003-2004 EMBS-BMES Distinguished Lecture
Serie</title></head><body>
<blockquote type="cite" cite>
<blockquote type="cite" cite>Date: Wed, 03 Dec 2003 23:39:33 -0500<br>
To: bmes-members@mit.edu, bmes-request@mit.edu<br>
From: Mandy Yeung <mandyy@mit.edu><br>
Subject: 2003-2004 EMBS-BMES Distinguished Lecture Series--December
10th, 7pm, Rm 66-110</blockquote>
<blockquote type="cite" cite><br>
Dear colleagues and friends,<br>
<br>
The Boston chapter of the Institute of Electrical and Electronics
Engineers<br>
(IEEE)-Engineering in
Medicine and Biology Society (EMBS)<br>
<span
></span
> <span
></span>
&<br>
<span
></span> the MIT Biomedical Engineering Society (BMES)<br>
<span
></span
> <span
></span> proudly present:<br>
<br>
*** The 2003-2004 EMBS-BMES
Distinguished Lecture Series ***<br>
<br>
We invite you to join us for our new monthly lecture series in which
we explore<br>
recent developments and stimulating topics in the expanding field of
biomedical<br>
engineering. In the fall, speakers from both academia and
industry will introduce such<br>
subjects as genes, genomics, proteomics, and systems biology.<br>
<br>
Our second lecture will be:<br>
<br>
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<br>
The Emerging Biological Engineering Discipline -- New Directions and
Opportunities<br>
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<br>
<br>
Douglas A Lauffenburger, Ph.D.<br>
Uncas & Helen Whitaker Professor and Director<br>
Biological Engineering Division<br>
Massachusetts Institute of Technology<br>
<br>
Wednesday, December 10th, 2003<br>
7PM (Refreshments at 6:30PM)<br>
MIT Building 66, 77 Massachusetts Ave., Room 66-110<br>
<x-tab> </x-tab>(For directions to MIT, please visit
http://whereis.mit.edu)<br>
<br>
* This event is free and open to the public.*<br>
<br>
*********************************************************************<span
></span>***<br>
<br>
ABSTRACT:<br>
<br>
A new biology-based engineering discipline, termed Biological
Engineering at MIT, is emerging which takes modern biology as its
central science base and fuses it with appropriate quantitative and
integrative analytical and synthetic approaches toward goals of: [a]
increasing fundamental understanding of how biological systems
operate; and [b] creating innovative biotechnologies directed toward a
diverse spectrum of application areas -- prominently emphasizing
medicine and human health, but also including other areas of societal
importance.<br>
<br>
This talk will offer an overview of this new discipline, focusing on
novel directions in research, education, and career opportunities
being pursued in the MIT Biological Engineering Division.<br>
<br>
<br>
SPEAKER BACKGROUND:<br>
<br>
Douglas A. Lauffenburger is Uncas & Helen Whitaker Professor of
Bioengineering in the Biological Engineering [BE] Division, Biology
Department, and Chemical Engineering Department and is a Member of the
Center for Cancer Research, Center for Biomedical Engineering, and
Biotechnology Process Engineering Center at MIT. He serves as
Director of the BE Division Director and on the Executive Committee of
the MIT Computational & Systems Biology Initiative. <br>
<br>
Dr. Lauffenburgerís BS and PhD degrees are in chemical engineering
from the University of Illinois and the University of Minnesota, in
1975 and 1979 respectively. His major research interests are in
cell engineering: the fusion of engineering with molecular cell
biology. A central focus of his research program is in
receptor-mediated cell communication and intracellular signal
transduction, with emphasis on development of predictive computational
models derived from quantitative experimental studies, for cell
cue/signal/response relationships important in pathophysiology with
application to drug discovery and development. Lauffenburger has
coauthored a monograph entitled<i> Receptors: Models for Binding,
Trafficking & Signaling</i>, published by Oxford University Press
in 1993 and reprinted in 1996. More than 50 doctoral students
and postdoctoral associates have completed their training under his
supervision or co-supervision.<br>
<x-tab> </x-tab><br>
Prof. Lauffenburger has served as a consultant or scientific advisory
board member for Astra-Zeneca, CellPro, Entelos, Insert Therapeutics,
Johnson & Johnson, Pfizer, SyStemix, the Burroughs-Wellcome
Foundation, and the Whitaker Foundation<i>.</i> His awards
include the A.P. Colburn Award, Bioengineering Division Award, and
W.H. Walker Award from AIChE, the Distinguished Lecture Award from
BMES, the C.W. McGraw Award from ASEE, the Amgen Award in Biochemical
Engineering from the Engineering Foundation, and a J.S. Guggenheim
Fellowship, along with a number of named lectures at academic
institutions. He is a member of the National Academy of
Engineering and of the American Academy of Arts & Sciences, and
has served as President of the Biomedical Engineering Society, Chair
of the College of Fellows of AIMBE, and on the Advisory Council for
the National Institute for General Medical Sciences at
NIH. </blockquote>
<blockquote type="cite" cite><br>
<br>
*********************************************************************<span
></span>***<br>
<br>
If you have any questions, please do not hesitate to contact us.
We look<br>
forward to seeing you!<br>
<br>
<br>
Best Regards,<br>
<br>
Mandy Yeung<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>Alexis DeSieno<br>
VP of Special Programs<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>President<br>
BMES,MIT Chapter<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>BMES, MIT Chapter<br>
mandyy@mit.edu<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>alexisd@mit.edu</blockquote>
</blockquote>
<div><br></div>
</body>
</html>